Laboratory Corporation of America Holdings (LH)
NYSE: LH · IEX Real-Time Price · USD
206.83
-3.76 (-1.79%)
May 20, 2024, 4:00 PM EDT - Market closed
LH Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for LH stock have an average target of 242, with a low estimate of 210 and a high estimate of 270. The average target predicts an increase of 17.00% from the current stock price of 206.83.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for LH stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
---|---|---|---|---|---|---|
Strong Buy | 4 | 4 | 3 | 4 | 4 | 4 |
Buy | 6 | 5 | 6 | 6 | 6 | 6 |
Hold | 2 | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 12 | 12 | 12 | 13 | 13 | 13 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Truist Securities | Truist Securities | Strong Buy Maintains $270 → $255 | Strong Buy | Maintains | $270 → $255 | +23.29% | Apr 26, 2024 |
Barclays | Barclays | Hold Maintains $234 → $213 | Hold | Maintains | $234 → $213 | +2.98% | Apr 26, 2024 |
Baird | Baird | Buy Maintains $255 → $244 | Buy | Maintains | $255 → $244 | +17.97% | Apr 26, 2024 |
Argus Research | Argus Research | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Mar 25, 2024 |
Leerink Partners | Leerink Partners | Buy Initiates $260 | Buy | Initiates | $260 | +25.71% | Feb 26, 2024 |
Financial Forecast
Revenue This Year
13.14B
from 12.16B
Increased by 8.03%
Revenue Next Year
13.71B
from 13.14B
Increased by 4.35%
EPS This Year
15.27
from 4.77
Increased by 220.06%
EPS Next Year
16.55
from 15.27
Increased by 8.38%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 13.5B | 14.2B | 15.3B | 16.3B | 17.2B |
Avg | 13.1B | 13.7B | 14.3B | 14.9B | 15.5B |
Low | 12.4B | 12.6B | 12.9B | 13.2B | 13.5B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 10.8% | 8.3% | 11.9% | 13.8% | 14.8% |
Avg | 8.0% | 4.4% | 4.5% | 4.3% | 3.8% |
Low | 1.8% | -3.8% | -5.8% | -7.7% | -9.6% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 15.75 | 17.66 | 19.54 | 21.06 | 23.46 |
Avg | 15.27 | 16.55 | 18.24 | 19.58 | 21.09 |
Low | 14.16 | 15.07 | 15.79 | 18.00 | 18.63 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 230.2% | 15.7% | 18.1% | 15.5% | 19.8% |
Avg | 220.1% | 8.4% | 10.2% | 7.4% | 7.7% |
Low | 196.9% | -1.3% | -4.6% | -1.3% | -4.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.